• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Pediatrics

The Bipolar-at-risk criteria may help screen for young individuals at risk of bipolar disorder

byRhianna DavisandAlex Chan
October 16, 2023
in Pediatrics, Psychiatry
Reading Time: 3 mins read
Clinic visits collage: a young man in a sweater between a desk with a closed laptop, a blank clipboard and an exam table
Share on FacebookShare on TwitterShare on LinkedIn

1. Compared to those who screened negative, individuals who screened positive via the Bipolar At-Risk Criteria were more likely to develop bipolar disorder at a 10-13-year follow-up. 

Evidence Rating Level: 2 (Good)

Study Rundown: Bipolar disorder (BD) is a mental illness affecting 2-3% of the global population. The bipolar at-risk (BAR) criteria is a screening tool used to identify those at risk of developing BD over 1-2 years. To screen positive via the BAR criteria, an individual must be between the ages 15 and 25, experienced subthreshold mania, depression, cyclothymic features, and have genetic susceptibility (a family history of BD). The ability of this tool to predict the development of BD over a more extended time period has not previously been studied. The authors recruited 60 participants aged 15-25 who were seeking mental health-related care. 28 of these participants met the BAR criteria, and 32 were in the comparison group. Over a 10-13 year follow-up period, the risk of developing BD I or II was significantly greater among the BAR group than the comparison group (8 individuals compared to 0). Overall, this study demonstrates that the BAR criteria are useful for identifying those at risk for developing BD over an approximately decade-long follow-up period. These criteria may be useful in clinical practice to identify individuals who would benefit from greater mental health support. 

Click to read the study in JAMA Network Open 

In-Depth [prospective cohort]: The authors recruited 69 individuals between the ages of 15 and 25 in Melbourne Australia. Participants were seeking help for non-psychotic mental health-related challenges, including mood, personality, and substance-use disorders. The mean age at follow-up was 32.9 years (SD 2.8), with 11.8% attrition. Participants were 81.7% female, 16.7% male, and 1.6% nonbinary. 28 participants met the BAR criteria, with 32 in the comparison group. 28.6% of participants in the BAR group had developed BD I or II over the 10-13 year follow-up period, compared to 0% of participants in the comparison group. The risk of developing BD was therefore significantly higher for those who screened positive via the BAR criteria (χ21 = 70.0; P < .001). The transition to BD was equally likely to occur during the first and second halves of the follow-up period. Of those who developed BD, 87.5% were diagnosed with BDII and 12.5% with BDI.  This study suggests that the BAR criteria are useful for identifying individuals at risk for developing BD over an approximately 10-year period. In clinical practice, the BAR criteria may be applied to adolescents and young adults seeking mental health care, to identify those who would benefit from greater support and monitoring for BD. A limitation of the study is that 11.8% of participants were not assessed at the time of follow-up. Given that those with more severe mental illness may be less likely to follow up, this attrition rate could skew the data. As well, the study sample size is relatively small. Future studies should aim to replicate this data among a larger cohort. 

Image: PD

RELATED REPORTS

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

Melatonin use is associated with lower proportions of rapid eye movement sleep in children

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: bipolarBipolar Disorderdevelopmental psychiatrypediatrics
Previous Post

Spiritual well-being may be associated with improvements in pain intensity and catastrophizing in patients with chronic pain

Next Post

Maintenance Olaparib Rechallenge in Platinum-Sensitive Relapsed Ovarian Cancer

RelatedReports

Newborn health collage: a pair of knitted baby booties on a folded blanket below a teal paper heart
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Childhood illness and sleep collage: a girl asleep under a quilt with a teddy bear, a medicine bottle and a night-light
Pediatrics

Melatonin use is associated with lower proportions of rapid eye movement sleep in children

August 14, 2026
Child health collage: a smiling girl with hair puffs, an open lunchbox with a sandwich, carrots and grapes, and a sneaker
Chronic Disease

The association between parental and offspring body mass index may be due to genetic confounding

June 30, 2026
Prenatal antidepressant exposure may increase risk of poor motor development
Chronic Disease

Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric

May 6, 2026
Next Post

Maintenance Olaparib Rechallenge in Platinum-Sensitive Relapsed Ovarian Cancer

Adenocarcinoma is the most prevalent lung cancer subtype and has a greater incidence rate in males than females

Fotagliptin monotherapy with alogliptin may be effective for uncontrolled type 2 diabetes

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • In At-Risk Patients With Moderate Aortic Stenosis, TAVR Reduced 2-Year Death or Heart-Failure Events
  • Nipocalimab patient interviews identify mouth dryness as the most important symptom to improve in phase 2 Sjögren’s disease data
  • CDC reports 5,182 confirmed measles cases in the United States in 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.